Novel inhibitors of the high-affinity l-proline transporter as potential therapeutic agents for the treatment of cognitive disorders

G. Greg Zipp, Joseph Barbosa, Michael A. Green, Kristen M. Terranova, Cynthia Fink, Xuan Chuan Yu, Amr Nouraldeen, Alan Wilson, Katerina Savelieva, Thomas H. Lanthorn, Spencer Kimball

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The incidence of cognitive disorders such as Alzheimer's disease continues to increase unabated. While cures for such diseases have eluded investigators, progress is being made on alleviating certain symptoms of these diseases. Mouse knockouts of the proline transporter (PROT), a high affinity Na +/Cl--dependent transporter, indicated its potential as a novel therapeutic target for cognition improvement. Herein we report our investigation into a novel class of PROT inhibitors.

Original languageEnglish (US)
Pages (from-to)3886-3890
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume24
Issue number16
DOIs
StatePublished - Aug 15 2014
Externally publishedYes

Fingerprint

Knockout Mice
Cognition
Alzheimer Disease
Research Personnel
Incidence
Therapeutics
proline transporter

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Zipp, G. Greg ; Barbosa, Joseph ; Green, Michael A. ; Terranova, Kristen M. ; Fink, Cynthia ; Yu, Xuan Chuan ; Nouraldeen, Amr ; Wilson, Alan ; Savelieva, Katerina ; Lanthorn, Thomas H. ; Kimball, Spencer. / Novel inhibitors of the high-affinity l-proline transporter as potential therapeutic agents for the treatment of cognitive disorders. In: Bioorganic and Medicinal Chemistry Letters. 2014 ; Vol. 24, No. 16. pp. 3886-3890.
@article{7ccbddab6ed44b4a96205b0a215fe049,
title = "Novel inhibitors of the high-affinity l-proline transporter as potential therapeutic agents for the treatment of cognitive disorders",
abstract = "The incidence of cognitive disorders such as Alzheimer's disease continues to increase unabated. While cures for such diseases have eluded investigators, progress is being made on alleviating certain symptoms of these diseases. Mouse knockouts of the proline transporter (PROT), a high affinity Na +/Cl--dependent transporter, indicated its potential as a novel therapeutic target for cognition improvement. Herein we report our investigation into a novel class of PROT inhibitors.",
author = "Zipp, {G. Greg} and Joseph Barbosa and Green, {Michael A.} and Terranova, {Kristen M.} and Cynthia Fink and Yu, {Xuan Chuan} and Amr Nouraldeen and Alan Wilson and Katerina Savelieva and Lanthorn, {Thomas H.} and Spencer Kimball",
year = "2014",
month = "8",
day = "15",
doi = "10.1016/j.bmcl.2014.06.049",
language = "English (US)",
volume = "24",
pages = "3886--3890",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "16",

}

Zipp, GG, Barbosa, J, Green, MA, Terranova, KM, Fink, C, Yu, XC, Nouraldeen, A, Wilson, A, Savelieva, K, Lanthorn, TH & Kimball, S 2014, 'Novel inhibitors of the high-affinity l-proline transporter as potential therapeutic agents for the treatment of cognitive disorders', Bioorganic and Medicinal Chemistry Letters, vol. 24, no. 16, pp. 3886-3890. https://doi.org/10.1016/j.bmcl.2014.06.049

Novel inhibitors of the high-affinity l-proline transporter as potential therapeutic agents for the treatment of cognitive disorders. / Zipp, G. Greg; Barbosa, Joseph; Green, Michael A.; Terranova, Kristen M.; Fink, Cynthia; Yu, Xuan Chuan; Nouraldeen, Amr; Wilson, Alan; Savelieva, Katerina; Lanthorn, Thomas H.; Kimball, Spencer.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 24, No. 16, 15.08.2014, p. 3886-3890.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Novel inhibitors of the high-affinity l-proline transporter as potential therapeutic agents for the treatment of cognitive disorders

AU - Zipp, G. Greg

AU - Barbosa, Joseph

AU - Green, Michael A.

AU - Terranova, Kristen M.

AU - Fink, Cynthia

AU - Yu, Xuan Chuan

AU - Nouraldeen, Amr

AU - Wilson, Alan

AU - Savelieva, Katerina

AU - Lanthorn, Thomas H.

AU - Kimball, Spencer

PY - 2014/8/15

Y1 - 2014/8/15

N2 - The incidence of cognitive disorders such as Alzheimer's disease continues to increase unabated. While cures for such diseases have eluded investigators, progress is being made on alleviating certain symptoms of these diseases. Mouse knockouts of the proline transporter (PROT), a high affinity Na +/Cl--dependent transporter, indicated its potential as a novel therapeutic target for cognition improvement. Herein we report our investigation into a novel class of PROT inhibitors.

AB - The incidence of cognitive disorders such as Alzheimer's disease continues to increase unabated. While cures for such diseases have eluded investigators, progress is being made on alleviating certain symptoms of these diseases. Mouse knockouts of the proline transporter (PROT), a high affinity Na +/Cl--dependent transporter, indicated its potential as a novel therapeutic target for cognition improvement. Herein we report our investigation into a novel class of PROT inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=84905917524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905917524&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2014.06.049

DO - 10.1016/j.bmcl.2014.06.049

M3 - Article

C2 - 25037917

AN - SCOPUS:84905917524

VL - 24

SP - 3886

EP - 3890

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 16

ER -